| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/12/2012 | US20120009121 Psma-targeting compounds and uses thereof |
| 01/11/2012 | EP2404903A1 Method of synthesizing [18f]sfb using microsynthesis technique |
| 01/11/2012 | EP2404899A1 Contrast medium for thrombus detection |
| 01/11/2012 | EP1572074B1 Stabilized synthetic immunogen delivery system |
| 01/11/2012 | EP1191947B1 Methods for treating avm' using radioactive compositions |
| 01/11/2012 | CN1767078B Preparation of radium-223, physically accepted preparation and kit |
| 01/11/2012 | CN102317257A Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 01/11/2012 | CN102316903A PDGF-RBeta BINDERS |
| 01/11/2012 | CN102311460A Carbonyl-technetium-labeled chlorambucil complex as well as preparation method and application thereof |
| 01/11/2012 | CN102311459A Novel technetium-99m-labeled higher fatty acid derivative |
| 01/11/2012 | CN102311458A <99m>TcO-nucleus-labeled chlorambucil complex as well as preparing and separating and purifying methods and application thereof |
| 01/11/2012 | CN101874899B Dopamine transporter imaging medicine and preparation method thereof |
| 01/10/2012 | US8093354 Process for preparing glycopeptide phosphonate derivatives |
| 01/10/2012 | US8092782 Polybiotin compounds of magnetic resonance imaging and drug delivery |
| 01/10/2012 | US8092779 Post-biopsy cavity treatment implants and methods |
| 01/10/2012 | CA2522308C Radioactively marked microparticles, method for the production thereof and use of the same |
| 01/05/2012 | WO2012003073A1 L-methylfolate treatment for psychiatric or neurologic disorders |
| 01/05/2012 | WO2012002388A1 Drug delivery agent to sentinel lymph node |
| 01/05/2012 | WO2012000863A1 Aptamer complex for detecting a diseased tissue |
| 01/05/2012 | WO2012000861A1 11c-labelled aptamer for detecting a diseased tissue |
| 01/05/2012 | WO2012000843A1 11c-labelled peptide for detecting an antigen |
| 01/05/2012 | WO2012000841A2 11c-labelled peptide for detecting an antibody |
| 01/05/2012 | WO2012000791A2 Diagnostic for localizing a diseased tissue |
| 01/05/2012 | WO2012000784A1 11c-labelled peptide for detecting neurons which express an acetylcholine receptor |
| 01/05/2012 | WO2012000781A2 11c-labelled peptide for detecting a tumour which expresses a somatostatin receptor |
| 01/05/2012 | WO2012000764A1 11c-labelled peptide for detecting a tumour which expresses a bombesin receptor |
| 01/05/2012 | WO2012000763A1 11c-marked peptide for detecting a diseased tissue that expresses an igf receptor |
| 01/05/2012 | WO2012000749A1 11c-labelled peptide for detecting a tumour which expresses a peptide transporter |
| 01/05/2012 | WO2012000746A1 11c-labelled peptide for detecting diseased tissue which expresses a chemokine receptor |
| 01/05/2012 | WO2012000134A1 Composite type radioactive isotope sealed seed source |
| 01/05/2012 | WO2011143360A8 Compositions, methods and systems for the synthesis and use of imaging agents |
| 01/05/2012 | US20120003154 Aryloxyanilide derivatives |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | US20120003152 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 01/05/2012 | US20120003151 Method for early imaging of atherosclerosis |
| 01/05/2012 | US20120003150 Therapeutic ribonucleases |
| 01/05/2012 | US20120003149 Novel monoclonal antibody, and use thereof |
| 01/05/2012 | US20120003148 Radioimmunotherapy and imaging of tumor cells that express viral antigens |
| 01/05/2012 | DE102010026066A1 11C-markiertes Aptamer zur Detektion eines krankhaften Gewebes 11C-labeled aptamer for detection of diseased tissue |
| 01/05/2012 | DE102010026065A1 11C-markiertes Peptid zur Detektion eines Tumors, der einen Bombesin-Rezeptor exprimiert 11C-labeled peptide for detection of a tumor that expresses a bombesin receptor |
| 01/05/2012 | DE102010026064A1 11C-markiertes Peptid zur Detektion eines krankhaften Gewebes 11C-labeled peptide for the detection of diseased tissue |
| 01/05/2012 | DE102010026063A1 11C-markiertes Peptid zur Detektion eines krankhaften Gewebes 11C-labeled peptide for the detection of diseased tissue |
| 01/05/2012 | DE102010026062A1 Aptamer-Komplex zur Detektion eines krankhaften Gewebes Aptamer complex for detection of diseased tissue |
| 01/05/2012 | DE102010026061A1 11C-markiertes Peptid zur Detektion eines Tumors, der einen Her2/neu-Rezeptor exprimiert 11C-labeled peptide for the detection of a tumor that expresses a Her2 / neu receptor |
| 01/05/2012 | DE102010026060A1 11C-markiertes Peptid zur Detektion eines Tumors, der einen Somatostatinrezeptor exprimiert 11C-labeled peptide for detection of a tumor expressing a somatostatin receptor |
| 01/05/2012 | DE102010026059A1 11C-markiertes Peptid zur Detektion eines krankhaften Gewebes, das einen Chemokinrezeptor exprimiert 11C-labeled peptide for the detection of abnormal tissue that expresses a chemokine receptor |
| 01/05/2012 | DE102010026058A1 11C-markiertes Peptid zur Detektion eines Antikörpers 11C-labeled peptide for the detection of an antibody |
| 01/05/2012 | DE102010026057A1 Diagnostikum zur Lokalisation eines krankhaften Gewebes Diagnostic tool for the localization of diseased tissue |
| 01/05/2012 | DE102010026056A1 11C-markiertes Peptid zur Detektion eines Tumors, der einen Peptidtransporter exprimiert 11C-labeled peptide for the detection of a tumor that expresses a peptide transporter |
| 01/05/2012 | DE102010026054A1 11C-markiertes Peptid zur Detektion eines Antigens 11C-labeled peptide for the detection of an antigen |
| 01/05/2012 | DE102010026053A1 11C-markiertes Peptid zur Detektion von Neuronen, die einen Acetylcholinrezeptor exprimieren 11C-labeled peptide for the detection of neurons expressing an acetylcholine receptor |
| 01/05/2012 | DE102010026052A1 11C-markiertes Peptid zur Detektion eines krankhaften Gewebes, das einen IGF-Rezeptor exprimiert 11C-labeled peptide for the detection of abnormal tissue that expresses an IGF receptor |
| 01/04/2012 | EP2400992A1 Methods and compositions for protein labelling |
| 01/04/2012 | EP2400991A1 Radiolabelled pde10 ligands |
| 01/04/2012 | CN102307858A Molecular probe precursor for pancreatic islet imaging and use of same |
| 01/04/2012 | CN102304179A GLP-1 and exendin related invention |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN101918039B Use of novel compound having affinity for amyloid, and process for production of the same |
| 01/04/2012 | CN101624593B siRNA tumor developer and siRNA thereof |
| 01/03/2012 | US8088726 Process for producing sustained-release composition |
| 01/03/2012 | US8088357 Tumor-specific recognition molecules |
| 01/03/2012 | CA2399293C Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 01/03/2012 | CA2378574C Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 12/29/2011 | WO2011163646A2 Methods for detection, diagnosis and selective eradication of neoplasms and circulating tumor cells using multidomain biotags |
| 12/29/2011 | WO2011163401A2 Colon and pancreas cancer specific antigens and antibodies |
| 12/29/2011 | WO2011160216A2 Compounds useful in imaging and therapy |
| 12/29/2011 | US20110318266 Phthalimide derivative metabotropic glutamate r4 ligands |
| 12/29/2011 | US20110318265 Coupled identification and treatment of cancer |
| 12/29/2011 | US20110318264 Methods and compositions for diagnosis and treatment of cancer |
| 12/29/2011 | CA2803392A1 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | CA2803391A1 Colon and pancreas cancer specific antigens and antibodies |
| 12/28/2011 | EP2399934A1 Novel monoclonal antibody, and use thereof |
| 12/28/2011 | EP2399612A1 Composition for labeling tissues of central nervous system, method for labeling tissues of central nervous system, and screening method using the composition for labeling tissues of central nervous system |
| 12/28/2011 | EP2398504A1 Methods and kits for diagnosis of cancer and prediction of therapeutic value |
| 12/28/2011 | EP1999109B1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 12/28/2011 | EP1945622B1 Isotopically-labeled benzofuran compounds as imagingagents for amyloidogenic proteins |
| 12/28/2011 | CN102300866A 作为放射性药物的含氮大环共轭物 As the nitrogen-containing macrocyclic radiopharmaceutical conjugates |
| 12/28/2011 | CN102300842A 放射性碘标记方法 Radioactive iodine labeling method |
| 12/28/2011 | CN102300590A 双功能螯合剂与甘露糖基人血清白蛋白的复合物 Bifunctional chelating agents and mannose-based human serum albumin complexes |
| 12/28/2011 | CN102300589A 用于帕金森氏病症的体内成像方法 Disorders in vivo imaging method for Parkinson's |
| 12/28/2011 | CN102295685A 一种<sup>18</sup>F标记的PRGD2化合物、其药盒、药盒制备方法及应用 One kind of <sup> 18 </ sup> PRGD2 F-labeled compounds, their kit, kit preparation method and application |
| 12/27/2011 | US8084583 RS7 antibodies |
| 12/27/2011 | US8084580 Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them |
| 12/27/2011 | US8084462 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 12/27/2011 | US8084045 Pharmaceutical formulations for the prolonged release of active principle(s) and their applications |
| 12/27/2011 | US8084029 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
| 12/27/2011 | US8084016 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 12/27/2011 | US8084015 Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide |
| 12/22/2011 | WO2011159789A2 Tritiated planar carbon forms |
| 12/22/2011 | US20110313230 Specific binding proteins and uses thereof |
| 12/22/2011 | US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 12/22/2011 | US20110311447 Compounds comprising 4-benzoylpiperidine as a Sigma-1-selective ligand |
| 12/22/2011 | US20110311446 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 12/22/2011 | US20110311445 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 12/22/2011 | US20110311443 Pharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient |
| 12/22/2011 | US20110311442 Direct cellular energy delivery system |
| 12/22/2011 | CA2802735A1 Tritiated planar carbon forms |
| 12/21/2011 | EP2396040A1 Use of buffers for radionuclide complexation |
| 12/21/2011 | EP1926729B1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |